Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00069589 · ClinicalTrials.gov registry record
Alopecia Areata Registry
A clinical trial of Alopecia Areata and Alopecia Totalis, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 3,100
- Enrollment target
- 5
- Study locations
NCT00069589 is a study of Alopecia Areata and Alopecia Totalis that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 3,100 participants, above the 1,836-participant average among 26 other Alopecia Areata trials with a reported enrollment target (69% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT00069589, a study of Alopecia Areata and Alopecia Totalis, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 3,100 participants
- Enrollment target
- 5
- Study locations
Study Summary
Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.
Conditions Studied
Study Locations (5)
California
- University of California, San Francisco - San Francisco
Colorado
- University of Colorado - UCHSC - Health Science Center at Fitzsimons - Aurora
Minnesota
- University of Minnesota - Minneapolis
New York
- Columbia University - New York
Texas
- M.D. Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,100 participants |
| Start Date | 2001-11 |
| Est. Completion | 2099-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00069589
The ClinicalTrials.gov registry entry for NCT00069589 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 3,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,836-participant average among 26 other Alopecia Areata trials with a reported enrollment target (69% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Alopecia Areata appearing as the primary indexed condition, and to 0 interventions.
NCT00069589 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00069589 about?
NCT00069589 is a clinical study titled "Alopecia Areata Registry". Alopecia areata is the loss of hair in patches that can proceed to loss of all hair (alopecia totalis or universalis). The purpose of the registry is to collect patient information and blood samples from people with alopecia areata.
What is the current status of trial NCT00069589?
This trial is currently active not recruiting. The enrollment target is 3,100 participants. The study started on 2001-11. Estimated completion is 2099-11.
What conditions does trial NCT00069589 study?
This clinical trial studies the following conditions: Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Autoimmune Hair Loss, Alopecia Partialis.
Who is sponsoring clinical trial NCT00069589?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00069589 being conducted?
This trial has 5 study locations across California, Colorado, Minnesota, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alopecia Areata
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
RECRUITING · Phase 2
-
A Study of LAD603 in Adults With Alopecia Areata
RECRUITING · Phase 2
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
RECRUITING · Phase 1
-
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
RECRUITING
-
Dupilumab in the Treatment of Pediatric Alopecia Areata
RECRUITING · Phase 2
-
Intralesional Cyclosporine for Alopecia Areata
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.